PHC-12-2014
PHC-12-2014
19 projects · €62,420,281 total EU contribution (project-level) · 26 participating organizations · 11 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€62,420,281
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (4)
- Italy (4)
- Netherlands (4)
- UK (4)
- France (3)
- IE (2)
- DK (1)
- EE (1)
- EL (1)
- Spain (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- Firalis2 projects · FR
- AG1 projects · NL
- AMONETA DIAGNOSTICS1 projects · FR
- BIMIND SAS1 projects · IT
- BIOATLAS OU1 projects · EE
- BIOSENSIA1 projects · IE
- Calcivis1 projects · UK
- CT1 projects · DE
- COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL1 projects · IT
- CYTO1 projects · UK
- DIATECH PHARMACOGENETICS S.R.L.1 projects · IT
- EPIGENOMICS1 projects · DE
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach ADVANTAGE · 666308 | H2020 | €3,583,396 | €3,337,197 | Details |
Lung cancEr fusiOn geNes: a new dIagnostic Device LEONID · 673953 | H2020 | €1,704,000 | €155,000 | Details |
RABIOPRED - Clinical validation of BIOmarker assay to PREDict treatment response in Rheumatoid Arthritis (RA) patients RABIOPRED · 666798 | H2020 | €4,995,250 | €4,995,250 | Details |
Development of a novel blood-based diagnostic test for colorectal cancer Colodetect · 666540 | H2020 | €2,309,447 | €2,490,073 | Details |
Prototyping 'intime' - a NINAAT-based self testing platform to detect infectious diseases intime · 666852 | H2020 | €4,526,324 | €0 | Details |
Validation of blood-brain-barrier permeability as a glioma biomarker by means of the radiotracer 99mTc-tetrofosmin and single-photon emission computer tomography GLIOMARK · 673737 | H2020 | €4,705,344 | €1,376,697 | Details |
Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy RAIL · 673780 | H2020 | €2,427,594 | €2,427,594 | Details |
Moving to Efficient Diabetes care: Multimode Integrated CO-morbidity diagnostics platform MEDMICO · 666676 | H2020 | €4,487,525 | €4,487,525 | Details |
Validation of a Lung Cancer Plasma Reflex Test Using Epigenetic Biomarker for Cancer Detection proLungPlasma · 672680 | H2020 | €2,772,528 | €2,772,528 | Details |
bLadder cAncer URine cEll aNalysis LAUREN · 673664 | H2020 | €3,135,925 | €3,135,925 | Details |